Designs on the Future of Health: The ambitions of Google, Apple, et al

Introduction

Introduction

The digital health revolution: tech giants and their impact on pharma

Drug discovery, quicker clinical trial recruitment, real word data generation, better patient adherence and improved diagnostics/monitoring. Dramatic change is underway as companies such as Google, Apple and Dell expand use of their digital health platforms. What are the organisational/cultural challenges industry must overcome and are tech giants friends or foes?

Designs on the future of Healthcare: the ambitions of Google, Apple et al provides a detailed 360-degree scan of current and upcoming digital technologies and technology players that will radically alter the way pharma conducts its business.

“Technology is forcing us to go beyond how we traditionally do things in terms of healthcare delivery, but also in terms of life sciences development. We are going much faster through the enabling technologies.”

Michael Greenberg, Sanofi Pasteur

Puchase Reasons

Answering key questions:

With this report you will be able to:

Key Topics explored

Expert Contributors

The report is informed through in-depth interviews with payers, advisors and clinicians. To ensure open and critical responses some contributors identities have been kept anonymous:

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Table of Contents
for Designs on the Future of Health: The ambitions of Google, Apple, et al

• 1 Executive Summary

  2 Methodology and objectives

  3 Expert Contributors

  4 Trends in the digital health transformation

  4.1 Investment trends

  4.1.1 Digital health investments

  4.1.2 Why are so many technology giants expanding in health and life sciences?

  4.1.3 Digital innovation labs

  4.1.4 Technology accelerators

  4.2 Consumer healthcare trends

  4.2.1 Non-traditional and on-demand care

  4.2.2 mHealth, bigger, but not yet better

  4.2.3 Personalised search powered by deep learning

  4.3 Healthcare technology trends

  4.3.1 Health IT interoperability

  4.3.1.1 US trends

  4.3.1.2 EU trends

  4.3.2 FHIR

  4.3.3 How are advanced technologies transforming healthcare and life sciences?

  4.3.4 What are the most significant trends driving technological transformation in health and life sciences?

  4.4 Trends in innovation models

  4.4.1 What innovation model is key to your process and philosophy?

  4.4.2 Design thinking

  4.4.2.1 Case study: Design thinking, a pharma company view

  4.4.2.2 Case study: Design thinking, a technology company view

  5 Technology giants in health and life sciences

  5.1 Which tech giants are showing the most promise in health and life sciences?

  5.2 Google, now Alphabet

  5.2.1 Google Ventures

  5.2.1.2 Flatiron Health

  5.2.1.3 Roche leads investment in Flatiron Health

  5.2.2 DeepMind Health

  5.3 Apple

  5.3.1 Apple HealthKit API

  5.3.2 Apple ResearchKit

  5.3.3 Case study: The Mount Sinai ResearchKit Asthma Study

  5.3.3.1 Integration with Electronic Health Records

  5.3.3.2 Advice to pharmaceutical companies on ResearchKit

  5.3.4 What are the lessons learned from Apple ResearchKit?

  5.3.5 Apple CareKit

  5.3.6 Apple Watch

  6 Pharma in the digital transformation

  6.1 How are digital technologies changing customers’ experiences with the pharma industry?

  6.2 What is pharma’s biggest weakness in digital health?

  6.3 How can pharma accelerate digital change?

  7 Technology deals

  7.1 Do you see pharma companies looking to form more technology partnerships in 2016?

  7.2 Is your pharma company looking to form more technology partnerships in 2016?

  7.3 Tech and pharma deals

  7.3.1 Alphabet/Google

  7.3.1.1 With Sanofi

  7.3.1.2 With Biogen

  7.3.1.3 With AbbVie

  7.3.1.4 With Novartis

  7.3.2 IBM

  7.3.2.1 With Novo Nordisk.

  7.4 Tech and other stakeholder deals

  7.4.1 Case study: Evolution of American Heart Association partnership with Verily

  7.4.1.2 What benefits does the partnership with Google provide?

  7.4.2 Is your technology company actively soliciting partnerships with the pharmaceutical industry?.

  7.4.3 What other opportunities does pharma have for innovation with external partners?

  8 Keys to successful partnerships for pharma

  8.1 Leadership

  8.1.1 What leadership qualities do pharma leaders need for successful technology collaborations?

  8.2 Technology companies as partners

  8.2.1 What do pharma leaders need to know about working with technology companies?.

  8.3 Healthcare CIOs as partners

  8.4 Patients as partners

  8.4.1 What are the keys to successful collaboration with patients?.

  9 The next five years

  9.1 Which areas of technology are the biggest opportunities for pharma?

  9.1.1 Big data and predictive analytics

  9.1.1.1 What is the biggest challenge in big data and analytics for health and life sciences in the next five years?

  9.1.2 Personalised/Precision Medicine

  9.1.2.1 How are digital technologies supporting your efforts in personalised medicine? What are the keys to advancing personalised or precision medicine?

  9.1.3 Drug discovery and development

  9.1.3.1 How will research change in the next five years?

  9.1.4 Genomics and the Electronic Health Record

  9.1.4.1 How will technology powerhouses advance genomic medicine? Do you see genomics becoming part of the EHR?

  9.1.5 Cognitive computing, artificial intelligence (AI) and deep learning

  9.1.5.1 How do you see cognitive computing and artificial intelligence changing health and life sciences?

  9.1.6 VR/AR for education and training

  9.1.6.1 What role will virtual reality/augmented reality have in digital health?

  9.1.7 Healthcare delivery

  9.1.7.1 How will big tech companies change the way healthcare is delivered over

  the next five years? What will this mean for HCPs, patients and carers?

  9.1.8 Implications for pharma

  9.1.8.1 To what extent will pharma be an essential partner in the digital health transformation?

  9.1.8.2 How and where must the pharma industry raise its level of commitment to digital health?

  9.1.8.3 How can leaders plan for skills gaps? What are the key areas?

  9.1.8.4 Where is the future value for pharma in partnering with tech companies in the digital health transformation?

  9.1.9 Closing thoughts on the future

  9.1.9.1 What is a forward-thinking technology that you personally believe has promise, and which do you feel will fail to establish a foothold?

  9.1.9.2 Will tech giants eclipse pharma in innovation?

  9.1.9.3 In conclusion

Additional Details

Publisher

FirstWord Pharma

Publisher Information

Reference

315 |

Report Format

PDF

Related Reports